Instrument for Glaucoma Early Detection and Monitoring

Status unconfirmed · Not applicable

Conditions studied: Glaucoma

In brief

To introduce a rapid and objective electrophysiological technique that can assess visual function in the magnocellular pathway, which is thought to be affected in early-stage glaucoma.

Key facts

Study ID

NCT00578110

Run by

Synabridge Corporation

People needed

180

Starts

2008-01-01

Expected to finish

2010-04-01

Last updated by the study team

2010-04-02

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age: 40 - 75 years old
• Visual acuity: 20/30 or better

You may not qualify if…

• Eye disease other than glaucoma

Where it is running

• School of Optometry, University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
• Yale Eye Center, Yale University — New Haven, Connecticut, United States (enrolling)
• Synabridge Corp. — Raritan, New Jersey, United States (enrolling)
• Hamilton Eye Institute, The University of Tennessee — Memphis, Tennessee, United States (enrolling)
• Edward S. Harkness Eye Institute, Columbia University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.